期刊文献+

柑橘属药材乙酸乙酯提取物抑制黄嘌呤氧化酶作用的谱效关系研究 被引量:2

Spectrum-effect relationship of ethyl acetate extracts from Chinese materia medica in Citrus on xanthine oxidase inhibitory activity
原文传递
导出
摘要 目的阐明不同柑橘属药材乙酸乙酯提取物指纹图谱特征峰对黄嘌呤氧化酶抑制作用的贡献程度。方法建立枳实、青皮、陈皮、橘红和香橼乙酸乙酯提取物指纹图谱,HPLC法测定黄嘌呤氧化酶一黄嘌呤反应体系尿酸生成量,评价各提取物对黄嘌呤氧化酶活性的影响,采用灰关联度分析法研究谱效关系,对照品比对法鉴定主要色谱峰。结果谱效关系分析表明,各药材提取物的黄嘌呤氧化酶抑制活性是多成分共同作用的结果,各色谱峰所代表的化学成分对抑制黄嘌呤氧化酶活性的贡献大小顺序为圣草次苷〉柚皮苷〉柚皮素〉橙皮苷〉桔皮素〉川陈皮素〉新橙皮苷〉橙皮素。结论不同柑橘属药材乙酸乙酯提取物指纹图谱特征峰与黄嘌呤氧化酶抑制作用有一定的对应关系。 Objective To explore the fingerprint characteristic peaks contribute to xanthine oxidase inhibitory activity of ethyl acetate extracts from medicinal and edible Chinese materia medica in Citrus, and to characterize the material basis. Methods The HPLC fingerprints of ethyl acetate extracts from Aurantii Fructus Immaturus, Citri Reticulatae Pericarpium Viride, Citri Reticulatae Pericarpium, Citri Exocarpium Rubrum, and Citri Fructus were established, and the degree of enzyme inhibition was calculated by measuring the formation amount of uric acid in the xanthine oxidase-xanthine reaction system. The spectrum-effect relationship was analyzed by grey relation analysis. The mainly characteristic peaks were identified by comparision with reference standards. Results The xanthine oxidase inhibitory activity was resulted from the combined action of multiple components. The contribution order was as follows: eriocitrin, naringin, naringenin, hesperidin, tangeretin, nobiletin, neohesperidin, and hesperetin, respectively. Conclusion The relationships between the fingerprint characteristic peaks of ethyl acetate extracts from Chinese materia medica in Citrus and xanthine oxidase inhibitory activity are paralleled to some extent.
机构地区 青岛大学药学院
出处 《国际中医中药杂志》 2016年第1期57-62,共6页 International Journal of Traditional Chinese Medicine
关键词 柑橘属 DNA指纹法 黄嘌呤氧化酶 谱效关系 灰关联度分析 Citrus DNA Fingerprinting Xanthine oxidase Spectrum-effect relationship Grey relational analysis
  • 相关文献

参考文献14

  • 1Ptmzi L, So A. Serum uric acid and gout:from the past to molecular biology [J]. Curr Med Res Opin, 2013, 29 (3) : S3-S8.
  • 2Puddu P, Puddu GM, Cravero E, et al. The relationship among hyperuricemia, endothelial dysfimcfion, and cardiovascular diseases:molecular mechanisms and clinical implications[J]. J Cardiol, 2012, 59(3) :235-242.
  • 3Zoccali C, Mallamaci F. Uric acid, hypertension, and cardiovascular and renal complications [J]. Curt Hypertens Rcp, 2013, 15 (6) :531-537.
  • 4Behradmancsh S, Horcstani MK, Baradaran A, et al. Association of serum uric acid with proteinuria in type 2 diabetic patients [J]. J Res Med Sci, 2013, 18 (1) : 44-46.
  • 5Pacher P, Nivorozhkin A, Szabo C. Therapeutic effects of xanthine oxidase inhibitors:renaissance half a century after the discovery of allopurinol[J]. Pharmacol Rev, 2006, 58(1) : 87-114.
  • 6Doghramji PP. Managing your patient with gout:a review of treatment options [J]. Postgrad Med, 2011,123 (3) : 56-71.
  • 7骆杨丽,曲玮,梁敬钰.柑橘属植物化学成分和药理作用研究进展[J].海峡药学,2013,25(7):1-6. 被引量:12
  • 8霍仕霞,康雨彤,彭晓明,高莉,闫明.高良姜提取物促进黑素生成的谱效关系分析[J].中草药,2013,44(8):995-1002. 被引量:15
  • 9耿媛媛,胡昌江,潘新,赵玲,熊瑞,张乐,胡麟.二神丸不同提取部位温脾止泻的谱效关系研究[J].中草药,2014,45(18):2658-2663. 被引量:21
  • 10刘小花,梁瑾,梁建娣,党子龙,封士兰.黄芪抗胃溃疡作用的谱效关系研究[J].中草药,2012,43(12):2448-2452. 被引量:22

二级参考文献68

共引文献95

同被引文献31

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部